The American Society of Plastic Surgeons (ASPS) has made a controversial move by advocating for a delay in gender-affirming surgeries for minors until the age of 19. This decision has sparked intense debate within the medical community and among advocates for transgender rights. The ASPS, in a recent statement, cited a lack of sufficient evidence to support the benefits of chest, genital, and facial surgeries for minors experiencing gender dysphoria, leaning on two highly debated publications for support. The group's stance diverges from several other major medical organizations, which have not changed their guidance on this politically charged issue.
The ASPS emphasizes that their position statement does not deny or minimize the distress of patients, but rather advocates for a balanced approach to care, especially for children and adolescents. They argue that compassionate and ethical care must consider scientific rigor, developmental factors, and long-term welfare. However, this statement is not a clinical guideline, and the society did not conduct an independent evidence assessment.
The shift in the ASPS's stance comes amidst pressure from the Trump administration to limit gender-affirming care for transgender individuals, particularly children. Deputy Health and Human Services Secretary Jim O'Neill praised the ASPS's decision, stating that it sets a scientific and medical standard for all provider groups to follow. However, other major medical associations have maintained their current guidelines, which already call for caution in surgery for minors.
Gender-affirming surgery is rare among U.S. children, and fewer than 1 in 1,000 adolescents receive gender-affirming medications. The American Academy of Pediatrics (AAP) does not make blanket recommendations for surgery for minors with gender dysphoria, emphasizing that decisions should be made collaboratively by patients, their families, and physicians, rather than politicians. The World Professional Association for Transgender Health (WPATH) also supports access to surgical care for minors under cautious guidelines and criteria, opposing a 'one-size-fits-all' approach.
The ASPS's statement acknowledges the 'variability in regulatory and legal environments' and the ethical, clinical, and legal risks associated with surgical decision-making. Dr. Scot Glasberg, who helped develop the statement, emphasized that the deliberations were not politically influenced and took time without external pressure. This decision has sparked further discussion and debate, with many questioning the ASPS's stance and its potential impact on transgender youth's access to necessary healthcare.
